Načítá se...
Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
PURPOSE: We are reporting the five-year biochemical control, toxicity profile and dosimetric parameters using iodine-125 low dose rate brachytherapy (BT) as monotherapy for early stage prostate cancer at a single institution. MATERIAL AND METHODS: Between April 2006 and December 2010, 169 men with e...
Uloženo v:
| Vydáno v: | Radiat Oncol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349732/ https://ncbi.nlm.nih.gov/pubmed/25880809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0349-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|